Literature DB >> 9486113

Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration.

M Cumberbatch1, R J Dearman, I Kimber.   

Abstract

The induction phase of contact sensitization is associated with the movement of epidermal Langerhans cells (LC) from the skin and their migration, via afferent lymphatics, to draining lymph nodes where they accumulate as immunostimulatory dendritic cells (DC). It has been demonstrated previously that tumour necrosis factor-alpha (TNF-alpha) provides an important signal for LC migration and that in the absence of this cytokine, movement of LC from the epidermis to regional lymph nodes is inhibited. Recent evidence indicates that interleukin-1 beta (IL-1 beta), a cytokine produced in murine epidermis exclusively by LC, may also play a role in LC migration. The purpose of the investigations described here was to clarify, using relevant neutralizing anti-cytokine antibodies, the contributions made by TNF-alpha and IL-1 beta to the migration of LC from the epidermis. It was found that like anti-TNF-alpha, anti-IL-1 beta administered systemically to mice (by intraperitoneal injection), prior to skin sensitization with the contact allergen oxazolone, resulted in a marked inhibition of DC accumulation in draining lymph nodes. It was shown also that anti-IL-1 beta inhibited TNF-alpha-induced LC migration and DC accumulation and that; in similar fashion, the stimulation of LC migration and DC accumulation induced by IL-1 beta was compromised by prior treatment with anti-TNF-alpha. Based upon these data it is proposed that the stimulation of LC migration in response to skin sensitization requires the receipt by LC of two independent signals, one provided by TNF-alpha and the other by IL-1 beta. Morphological analyses of LC in epidermal sheets prepared from animals exposed to these cytokines with or without prior systemic treatment with anti-cytokine antibody suggested that the changes induced in LC by TNF-alpha and IL-1 beta may include the altered expression of adhesion molecules and acquisition of the ability to interact with and pass through the basement membrane.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9486113      PMCID: PMC1363801          DOI: 10.1046/j.1365-2567.1997.00360.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

1.  Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells.

Authors:  B Wang; S Kondo; G M Shivji; H Fujisawa; T W Mak; D N Sauder
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

2.  Langerhans' cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens.

Authors:  Y Kobayashi
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

3.  Dendritic cell accumulation in draining lymph nodes during the induction phase of contact allergy in mice.

Authors:  A Kinnaird; S W Peters; J R Foster; I Kimber
Journal:  Int Arch Allergy Appl Immunol       Date:  1989

4.  Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization.

Authors:  M L Kripke; C G Munn; A Jeevan; J M Tang; C Bucana
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

5.  Interleukin 1 beta and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor alpha.

Authors:  M Cumberbatch; R J Dearman; I Kimber
Journal:  Arch Dermatol Res       Date:  1997-04       Impact factor: 3.017

6.  Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate.

Authors:  S E Macatonia; A J Edwards; S C Knight
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

7.  Adhesion molecule expression by epidermal Langerhans cells and lymph node dendritic cells: a comparison.

Authors:  M Cumberbatch; R J Dearman; I Kimber
Journal:  Arch Dermatol Res       Date:  1996-11       Impact factor: 3.017

8.  Effects of contact allergens on human Langerhans cells in skin organ culture: migration, modulation of cell surface molecules, and early expression of interleukin-1 beta protein.

Authors:  A Rambukkana; F H Pistoor; J D Bos; M L Kapsenberg; P K Das
Journal:  Lab Invest       Date:  1996-02       Impact factor: 5.662

9.  The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen.

Authors:  S C Knight; J Krejci; M Malkovsky; V Colizzi; A Gautam; G L Asherson
Journal:  Cell Immunol       Date:  1985-09       Impact factor: 4.868

10.  Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies.

Authors:  S E Macatonia; S C Knight; A J Edwards; S Griffiths; P Fryer
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

View more
  64 in total

Review 1.  In vivo maturation and migration of dendritic cells.

Authors:  L Flores-Romo
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

Review 2.  Tracking dendritic cells in vivo: insights into DC biology and function.

Authors:  Huiming Hon; Joshy Jacob
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Dendritic cells and the handling of antigen.

Authors:  F Dieli
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

Review 4.  Professional antigen-presenting cells of the skin.

Authors:  Alicia R Mathers; Adriana T Larregina
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Mechanisms of anti-carcinogenesis by indole-3-carbinol. Studies of enzyme induction, electrophile-scavenging, and inhibition of aflatoxin B1 activation.

Authors:  A T Fong; H I Swanson; R H Dashwood; D E Williams; J D Hendricks; G S Bailey
Journal:  Biochem Pharmacol       Date:  1990-01-01       Impact factor: 5.858

6.  Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue.

Authors:  A Porgador; H F Staats; Y Itoh; B L Kelsall
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

7.  Role of TNFalpha in early chemokine production and leukocyte infiltration into heart allografts.

Authors:  D Ishii; A D Schenk; S Baba; R L Fairchild
Journal:  Am J Transplant       Date:  2009-12-02       Impact factor: 8.086

Review 8.  Corneal pain and experimental model development.

Authors:  Tina B McKay; Yashar Seyed-Razavi; Chiara E Ghezzi; Gabriela Dieckmann; Thomas J F Nieland; Dana M Cairns; Rachel E Pollard; Pedram Hamrah; David L Kaplan
Journal:  Prog Retin Eye Res       Date:  2018-11-16       Impact factor: 21.198

9.  The haemopoietic growth factor, Flt3L, alters the immune response induced by transcutaneous immunization.

Authors:  Maria E Baca-Estrada; Catherine Ewen; Donna Mahony; Lorne A Babiuk; Darryl Wilkie; Marianna Foldvari
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

10.  TILRR, a novel IL-1RI co-receptor, potentiates MyD88 recruitment to control Ras-dependent amplification of NF-kappaB.

Authors:  Xiao Zhang; Freya Shephard; Hong B Kim; Ian R Palmer; Selina McHarg; Gregory J S Fowler; Luke A J O'Neill; Endre Kiss-Toth; Eva E Qwarnstrom
Journal:  J Biol Chem       Date:  2009-11-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.